/
/
/

Aspira Pathlab & Diagnostics Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
---67%
---176%
-13%55%113%
-4%-4%-4%18%

Peer Comparison

Symbol
APOLLOHOSP-A
MAXHEALTH-A
FORTIS-A
ASTERDM-A
MEDANTA-A
NH-A
KIMS-A
LALPATHLAB-A
VIJAYA-A
AGARWALEYE-A
ASPIRA-X
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
8,900₹130273 Cr62.3540.39207.67₹1942 Cr
1,047.5₹102446 Cr70.323.3119.84₹1442 Cr
878.75₹67267 Cr64.193.5320.1₹1042 Cr
770.55₹66295 Cr208.030.316.76₹388 Cr
1,502.25₹40209 Cr72.35.9129.85₹556 Cr
1,879.55₹39270 Cr48.1210.1465.36₹806 Cr
802₹33529 Cr164.121.0412.74₹241 Cr
1,958.8₹32271 Cr59.5510.1142.51₹505 Cr
1,531₹16149 Cr86.135.1627.53₹173 Cr
503₹15713 Cr105.911.4313.88₹133 Cr
129.5₹137 Cr57.110.413.77₹2 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Unsecured Loans
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024
——
₹10 Cr₹10 Cr
₹2 Cr-₹15 L
₹2 Cr-₹15 L
₹12 Cr₹10 Cr
₹1 Cr₹1 Cr
₹1 Cr₹1 Cr
₹55 L₹41 L
₹3 Cr₹2 Cr
——
₹74 L₹73 L
₹2 Cr₹1 Cr
₹5 L₹3 L
₹2 Cr₹2 Cr
₹17 Cr₹15 Cr
₹1 Cr₹1 Cr
₹1 Cr₹1 Cr
——
₹18 Cr₹17 Cr
₹12 Cr₹10 Cr
₹7 Cr₹7 Cr
₹8 L₹0
₹8 L₹0
₹4 Cr₹4 Cr
₹2 Cr₹0
₹12 Cr₹10 Cr
——
₹51 L₹45 L
₹2 Cr₹2 Cr
₹2 Cr₹1 Cr
₹8 L₹6 L
₹27 L₹22 L
₹5 Cr₹4 Cr
₹3 Cr₹2 Cr
₹17 Cr₹15 Cr
₹12₹10
₹12₹10

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024
₹2 Cr-₹3 Cr
₹2 Cr₹2 Cr
-₹2 Cr₹2 Cr
₹2 Cr₹1 Cr
₹2 Cr₹1 Cr
₹12 L₹14 L
-₹99 L-₹95 L
₹95 L₹24 L
₹80 L₹57 L
₹2 Cr₹80 L

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)138.99
Volume (₹)3,481.00
High (₹)138.99
Upper Circuit139.76
Low (₹)129.50
Lower Circuit126.46
Prev Close133.11
52W High (₹)138.99
Price129.50
52W Low (₹)49.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)137.01 Cr
Div. Yield (%)0.00
PE Ratio57.11
Debt to Equity0.10
Price to Book7.21
Book Value11.82
EPS (TTM)2.33
Face Value10.00
ROE (%)18.13

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
APOLLOHOSP-ANSE
MAXHEALTH-ANSE
FORTIS-ANSE
ASTERDM-ANSE
MEDANTA-ANSE
NH-ANSE
KIMS-ANSE
LALPATHLAB-ANSE
VIJAYA-ANSE
AGARWALEYE-ANSE
ASPIRA-XNSE
LTP
1W Low
1W High
Market cap (₹)
8900+129.75 (1.48%)
8816.40
9069
1,30,273Cr
1047.5-7.5 (-0.71%)
1029.20
1072
1,02,446Cr
878.75+3.75 (0.43%)
878.75
908.20
67,267Cr
770.55+14.7 (1.94%)
739.70
779.80
66,295Cr
1502.25-4.5 (-0.30%)
1400.90
1525.65
40,209Cr
1879.55-50.2 (-2.60%)
1871.50
1931.45
39,270Cr
802-9 (-1.11%)
786.45
818.85
33,529Cr
1958.8+62.95 (3.32%)
1888.90
1975
32,271Cr
1531-26.5 (-1.70%)
1507
1592
16,149Cr
503+3.2 (0.64%)
484.85
506
15,713Cr
129.5+14.5 (12.61%)
120.75
138.99
137Cr

Aspira Pathlab & Diagnostics Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹92.9Lakh; with other income of ₹10.8Lakh, profit before interest and tax came to ₹56.4Lakh. Interest expense was ₹9.4Lakh; PBT before exceptional items stood at ₹47Lakh. Basis: consolidated annual results.

Aspira Pathlab & Diagnostics Ltd Quaterly Results Key Takeaways

Aspira Pathlab & Diagnostics Ltd reported ₹5.25Cr total income from operations in Jun 2025, softer than ₹5.78Cr in Mar 2025 but higher than ₹4.64Cr in Jun 2024. Operating profit (before other income, interest and exceptional items) was ₹92.9Lakh; with other income of ₹10.8Lakh, profit before interest and tax came to ₹56.4Lakh. Interest expense was ₹9.4Lakh, taking profit before tax to ₹47Lakh. After tax of ₹0 cr, profit after tax stood at ₹47Lakh (vs ₹72.3Lakh in Mar 2025 and ₹-₹1.6Lakh in Jun 2024).